title: Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancer.
authors.affiliation: Section of Gastrointestinal Oncology and Digestive Diseases, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
authors.forename: J L
authors.initials: JL
authors.lastname: Abbruzzese
authors.forename: A
authors.initials: A
authors.lastname: Weeks
authors.forename: M N
authors.initials: MN
authors.lastname: Raber
authors.forename: D
authors.initials: D
authors.lastname: Gravel
authors.forename: R A
authors.initials: RA
authors.lastname: DuBrow
authors.forename: B
authors.initials: B
authors.lastname: Levin
authors.forename: J
authors.initials: J
authors.lastname: Grem
authors.forename: H G
authors.initials: HG
authors.lastname: Chun
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D012673:Semustine / Q000008:administration & dosage
chemical_list: D012673:Semustine; D002955:Leucovorin; D005472:Fluorouracil